Stay up-to-date with the latest news, trends and developments in iPSCs.
FDA Modernization Act 2.0: FDA no longer requires all drugs to be tested on animals before human trials
Press release: Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses through their next phase of growth
Press release: Ncardia launches Cellistic, an iPSC cell therapy CDMO
Press release: Ncardia Appoints Andy Holt as Chief Commercial Officer
Press release: Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings
Press release: Cell & gene therapy accelerator to de-risk early stage research